ClinicalTrials.Veeva

Menu
U

University of Ottawa | University of Ottawa Heart Institute - Lipid Clinic

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Rivaroxaban
Warfarin
VX-670
Capecitabine
enalapril
ZW25
hydralazine
Nitric Oxide
AOC 1020
Vinorelbine

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 71 total trials

A Phase 1/2 Study of VX-670 in Adult Participants With Myotonic Dystrophy 1 (DM1) (Galileo)

The purpose of the study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of VX-670 at different single and multiple d...

Enrolling
Myotonic Dystrophy Type 1 (DM1)
Drug: Placebo
Drug: VX-670

This study will assess the efficacy and safety of vamikibart in participants with uveitic macular edema.

Active, not recruiting
Uveitic Macular Edema
Other: Sham
Drug: Vamikibart

A Randomized, Double-blind, Placebo-controlled, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Explora...

Enrolling
Muscular Dystrophy, Landouzy Dejerine
Fascioscapulohumeral Muscular Dystrophy
Drug: AOC 1020
Drug: Placebo

The primary objective of this study is to demonstrate the efficacy of Iomab-B, in conjunction with a Reduced Intensity Conditioning (RIC) regimen and...

Active, not recruiting
AML
Bone Marrow Transplant
Drug: Conventional Care
Drug: Iomab-B

This is a first-in-human, 3-part study to investigate the safety, tolerability, and effectiveness of ZW25 (zanidatamab) by itself and combined with s...

Active, not recruiting
HER2-expressing Cancers
Drug: Capecitabine
Drug: ZW25 (Zanidatamab)

Trial sponsors

University of Ottawa logo
U
L
O
Abbott logo
Abbott logo
Actinium Pharmaceuticals logo
A
A
Boston Scientific logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems